Status: current, Primitive. Date: 28-Feb 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4676001000168118 | Cabazitaxel (MSN) (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4676011000168115 | Cabazitaxel (MSN) | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cabazitaxel (MSN) | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cabazitaxel (MSN) (inert substance) diluent, 4.5 mL vial | Is a | True | Cabazitaxel (MSN) | Inferred relationship | Some | |
| Cabazitaxel (MSN) (1 x 60 mg/1.5 mL vial, 1 x 4.5 mL inert diluent vial), 1 pack | has TP | True | Cabazitaxel (MSN) | Inferred relationship | Some | |
| Cabazitaxel (MSN) (cabazitaxel 60 mg/1.5 mL) injection, 1.5 mL vial | Is a | True | Cabazitaxel (MSN) | Inferred relationship | Some | |
| Cabazitaxel (MSN) (1 x 60 mg/1.5 mL vial, 1 x 4.5 mL inert diluent vial), 1 pack | has TP | True | Cabazitaxel (MSN) | Inferred relationship | Some |
Reference Sets
FHIR